Ascent Pediatrics Inc., Wilmington, DE, a new pharmaceutical firm devoted exclusively to products for children, launched its first three products in November of 1997.
Ascent Pediatrics Inc., Wilmington, DE, a new pharmaceutical firm devoted exclusively to products for children, launched its first three products in November of 1997.
The products are Feverall,® an acetaminophen suppository brand for fever reduction and pain relief; Just for Kids⢠Vitamin Drops, a liquid multivitamin; and Pediamist,® a nasal saline mist for relief of dry nasal passages. To specifically meet the needs of children, the products were developed to taste good, require reduced dosing frequency, have minimal side-effects and employ improved delivery systems.
A sales force of 65 pediatric sales specialists will contact pediatricians nationwide about the new products and the need for increased compliance among children. The pediatric market of children under the age of 12 in the United States is estimated at approximately 47 million.
"Children are not miniature adults and their needs are not the same as adults," said Emmett Clemente, Ph.D., Ascent Pediatric's founder and chairman. "Our strategy at Ascent is to meet the challenge of developing products with the goal of increasing compliance among children. After all, what good is a medicine if a child doesn't take it?" PR
Key Findings of the NIAGARA and HIMALAYA Trials
November 8th 2024In this episode of the Pharmaceutical Executive podcast, Shubh Goel, head of immuno-oncology, gastrointestinal tumors, US oncology business unit, AstraZeneca, discusses the findings of the NIAGARA trial in bladder cancer and the significance of the five-year overall survival data from the HIMALAYA trial, particularly the long-term efficacy of the STRIDE regimen for unresectable liver cancer.
Fake Weight Loss Drugs: Growing Threat to Consumer Health
October 25th 2024In this episode of the Pharmaceutical Executive podcast, UpScriptHealth's Peter Ax, Founder and CEO, and George Jones, Chief Operations Officer, discuss the issue of counterfeit weight loss drugs, the potential health risks associated with them, increasing access to legitimate weight loss medications and more.